Reduced-intensity conditioning regimen and allogeneic stem cell transplantation from related or unrelated HLA identical donor in neuroblastoma either refractory or relapsed after autologous stem cell transplantation

被引:0
|
作者
Prete, A.
Rondelli, R.
Lanino, E.
Pession, A.
Locatelli, F.
Zecca, M.
Messina, C.
Caselli, D.
Favre, C.
Rabusin, M.
Fagioli, F.
机构
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S88 / S88
页数:1
相关论文
共 50 条
  • [31] Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies
    Sureda, A
    Schmitz, N
    ANNALS OF HEMATOLOGY, 2003, 82 (01) : 1 - 13
  • [32] Neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation
    Barba, P.
    Pinana, J. L.
    Valcarcel, D.
    Martino, R.
    Sureda, A.
    Delgado, J.
    Briones, J.
    Brunet, S.
    Sierra, J.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S72 - S73
  • [33] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Plair, Tamera
    Alousi, Amin M.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Hagemeister, Frederick B.
    Oki, Yasuhiro
    Neelapu, Saatva
    Romaguera, Jorge E.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
  • [34] Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen
    Anderlini, P
    Saliba, R
    Acholonu, S
    Okoroji, GJ
    Donato, M
    Giralt, S
    Andersson, B
    Ueno, NT
    Khouri, I
    De Lima, M
    Hosing, C
    Cohen, A
    Ippoliti, C
    Romaguera, J
    Rodriguez, MA
    Pro, B
    Fayad, L
    Goy, A
    Younes, A
    Champlin, RE
    BONE MARROW TRANSPLANTATION, 2005, 35 (10) : 943 - 951
  • [35] Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin Era
    Anderlini, Paolo
    Saliba, Rima
    Ledesma, Celina
    Chancoco, Christina M.
    Alexander, Tamera R.
    Alousi, Amin M.
    Hosing, Chitra
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Oki, Yasuhiro
    Romaguera, Jorge E.
    Neelapu, Sattva S.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S72 - S72
  • [36] Reduced-intensity conditioning allogeneic stem cell transplantation for patients with refractory or relapsed non-Hodgkin lymphoma
    De Lavallade, H.
    Bouabdallah, R.
    Faucher, C.
    Furst, S.
    El Cheikh, J.
    Vey, N.
    Stoppa, A. M.
    Sainty, D.
    Arnoulet, C.
    Xerri, L.
    Cassier, P.
    Gastaut, J. A.
    Blaise, D.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S149 - S149
  • [37] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOLLOWING A REDUCED-INTENSITY CONDITIONING REGIMEN FOR TREATMENT OF REFRACTORY MYELOID LEUKEMIA
    Jiang, J.
    Wang, C.
    Yan, S.
    Wan, L.
    Yang, J.
    Cai, Y.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S549 - S549
  • [38] Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen
    P Anderlini
    R Saliba
    S Acholonu
    G-J Okoroji
    M Donato
    S Giralt
    B Andersson
    N T Ueno
    I Khouri
    M De Lima
    C Hosing
    A Cohen
    C Ippoliti
    J Romaguera
    M A Rodriguez
    B Pro
    L Fayad
    A Goy
    A Younes
    R E Champlin
    Bone Marrow Transplantation, 2005, 35 : 943 - 951
  • [39] Allogeneic reduced intensity conditioning regimen haematopoietic stem cell transplantation
    Fürst, S
    Dubois, V
    Michallet, AS
    Nicolini, F
    Thomas, X
    Troncy, J
    Rafii, H
    Gebuhrer, L
    Michallet, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S329 - S329
  • [40] Allogeneic stem cell transplantation after reduced-intensity conditioning in the patients with refractory malignant lymphoproliferative disorders
    Raida, L
    Faber, E
    Papajik, T
    Indrak, K
    Vitek, A
    Koza, V
    BONE MARROW TRANSPLANTATION, 2005, 35 : S244 - S244